Revised Code of Washington
Chapter 70.14 - Health Care Services Purchased by State Agencies.
70.14.130 - Health technology clinical committee—Public notice.

RCW 70.14.130
Health technology clinical committee—Public notice.

(1) The administrator shall develop a centralized, internet-based communication tool that provides, at a minimum:
(a) Notification when a health technology is selected for review under RCW 70.14.100, indicating when the review will be initiated and how an interested party may submit evidence, or provide public comment, for consideration during the review;
(b) Notification of any determination made by the committee under RCW 70.14.110(1), its effective date, and an explanation of the basis for the determination; and
(c) Access to the systematic assessment completed under RCW 70.14.100(4), and reports completed under subsection (2) of this section.
(2) Participating agencies shall develop methods to report on the implementation of this section and RCW 70.14.080 through 70.14.120 with respect to health care outcomes, frequency of exceptions, cost outcomes, and other matters deemed appropriate by the administrator.

[ 2006 c 307 § 7.]
NOTES:

Captions not law—Conflict with federal requirements—2006 c 307: See notes following RCW 70.14.080.

Structure Revised Code of Washington

Revised Code of Washington

Title 70 - Public Health and Safety

Chapter 70.14 - Health Care Services Purchased by State Agencies.

70.14.020 - State agencies to identify alternative health care providers.

70.14.030 - Health care utilization review procedures.

70.14.040 - Review of prospective rate setting methods.

70.14.050 - Drug purchasing cost controls—Establishment of evidence-based prescription drug program.

70.14.060 - Prescription drug purchasing consortium—Participation—Exceptions—Rules.

70.14.065 - Generic prescription drug partnership agreements.

70.14.070 - Prescription drug consortium account.

70.14.080 - Definitions.

70.14.090 - Health technology clinical committee.

70.14.100 - Health technology selection and assessment.

70.14.110 - Health technology clinical committee determinations.

70.14.120 - Agency compliance with committee determination—Coverage and reimbursement determinations for nonreviewed health technologies—Appeals.

70.14.130 - Health technology clinical committee—Public notice.

70.14.140 - Applicability to health care services purchased from health carriers.

70.14.150 - Data-sharing agreements—Report.

70.14.155 - Streamlined health care administration—Agency participation.

70.14.160 - Total cost of insulin work group—Appointment—Duties—Reporting.

70.14.165 - Total cost of insulin work group—Authority implementation.

70.14.170 - Opioid overdose reversal medications—Bulk purchasing and distribution—Rules—Report—Recommendation to legislature.

70.14.175 - Opioid overdose reversal medication account.